celecoxib and interleukin-8

celecoxib has been researched along with interleukin-8 in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (57.14)	29.6817
2010's	2 (28.57)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Chichorro, JG; Lorenzetti, BB; Zampronio, AR	1
Davis, DW; Ellis, LM; Khanbolooki, S; Lashinger, LM; McConkey, DJ; Nawrocki, S; Raut, CP; Xiong, H	1
Chatterjee, A; Fulzele, SV; Jackson, T; Shaik, MS; Singh, M	1
Balzarini, P; Bianchi, M; Broggini, M; Franchi, S; Sacerdote, P	1
Asmawidjaja, PS; Davelaar, N; Hazes, JM; Lubberts, E; Paulissen, SM; van Hamburg, JP	1
Gehrke, T; Hackenberg, S; Hagen, R; Ickrath, P; Kleinsasser, N; Schendzielorz, P; Scherzad, A	1
Alini, M; Benneker, L; Creemers, LB; Eglauf, J; Grad, S; Häckel, S; Häne, S; Hoppe, S; Lang, G; Li, Z; Ma, J; Peroglio, M; Pfannkuche, J; Soubrier, A; Wangler, S	1

Trials

1 trial(s) available for celecoxib and interleukin-8

Article	Year
Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. International journal of clinical practice, 2007, Volume: 61, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Celecoxib; Double-Blind Method; Female; Humans; Interleukin-6; Interleukin-8; Male; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Substance P; Sulfonamides; Synovial Fluid; Treatment Outcome	2007

Article

Year

Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.

International journal of clinical practice, 2007, Volume: 61, Issue:8

Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Celecoxib; Double-Blind Method; Female; Humans; Interleukin-6; Interleukin-8; Male; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Substance P; Sulfonamides; Synovial Fluid; Treatment Outcome

2007

Other Studies

6 other study(ies) available for celecoxib and interleukin-8

Article	Year
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. British journal of pharmacology, 2004, Volume: 141, Issue:7 Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine	2004
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. Cancer biology & therapy, 2004, Volume: 3, Issue:12 Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelial Cells; Fibroblast Growth Factor 2; Group IV Phospholipases A2; Humans; Indomethacin; Interleukin-8; Male; Membrane Proteins; Mice; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2004
Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model. Pharmaceutical research, 2006, Volume: 23, Issue:9 Topics: Administration, Inhalation; Aerosols; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Celecoxib; Dinoprostone; Docetaxel; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Injections, Intravenous; Interleukin-8; Lung Neoplasms; Mice; Neoplasm Transplantation; Pyrazoles; Sulfonamides; Taxoids; Transplantation, Heterologous	2006
Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23. Journal of immunology (Baltimore, Md. : 1950), 2013, Aug-01, Volume: 191, Issue:3 Topics: Arthritis, Rheumatoid; CD4 Antigens; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Fibroblasts; Humans; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-1beta; Interleukin-23 Subunit p19; Interleukin-6; Interleukin-8; Leukocyte Common Antigens; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Middle Aged; Pyrazoles; Receptors, CCR6; Sulfonamides; Synovial Membrane; Th17 Cells; Tumor Necrosis Factor-alpha	2013
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro. International journal of oncology, 2017, Volume: 51, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Interleukin-8; Simvastatin; Squamous Cell Carcinoma of Head and Neck	2017
Celecoxib alleviates nociceptor sensitization mediated by interleukin-1beta-primed annulus fibrosus cells. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2023, Volume: 32, Issue:6 Topics: Animals; Annulus Fibrosus; Bradykinin; Calcium; Cattle; Celecoxib; Cells, Cultured; Ganglia, Spinal; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Nociceptors; Tumor Necrosis Factor-alpha	2023